ReviewRheumatology international2025
The role of mesotherapy in chronic back pain syndrome: what do we know?
Review in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Blood biomarkers of inflammation and brain-derived neurotrophic factor can not be used to assess the effectiveness of collagen mesotherapy in chronic cervical myofascial pain syndrome. A pilot single-blind randomized study.Rheumatology international · 2026Trial
- The role of injectable porcine type I collagen (Tropocollagen) in chronic musculoskeletal disorders.Rheumatology international · 2026Review
- Current Perspective on Orthobiology Applications for the Treatment of Intervertebral Disc Degeneration (IDD)-A Narrative Review.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Back pain syndrome is one of the most prevalent disorders of the 21st century, frequently diagnosed by physicians across various medical specialties. A key clinical priority is to identify the underlying cause and establish an accurate diagnosis. A common etiological factor is the overload of soft tissues due to improper posture or movement, resulting in congestion, reduced mobility, and pain. Spinal mesotherapy, a minimally invasive injection technique, has gained attention for its ability to improve microcirculation, relax tense tissues, enhance range of motion, and, most importantly, alleviate pain. Increasingly, this treatment is being incorporated into a structured "three-step approach" to chronic back pain: risk factor assessment, medical intervention (such as spinal mesotherapy), and subsequent targeted physiotherapy. This narrative review analyzes nine studies involving more than 800 patients with chronic back pain syndrome. Across all included studies, mesotherapy demonstrated a consistent positive impact on both pain reduction and functional improvement, without reports of serious adverse events. The purpose of this review is to assess the current evidence on the efficacy and safety of spinal mesotherapy and to highlight its role within a multimodal treatment strategy for chronic back pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.